Moderna announces strategy to address new variant – .

0
20
Moderna announces strategy to address new variant – .


Moderna on Friday unveiled its strategy to combat the new COVID-19 B.1.1.529 variant known as Omicron, joining rivals Pfizer and Johnson & Johnson, who detailed their own plans on the same day.

The new variant of Omicron was discovered in South Africa, and the World Health Organization has identified it as a highly transmissible ‘variant of concern’ due to concerns that it may be a variant of Omicron. escape that eludes currently available coronavirus vaccines.

US President Joe Biden addresses the 76th session of the United Nations General Assembly on September 21, 2021 at UN headquarters in New York. (Photo by Timothy A. Clary-Pool / Getty Images) ((Photo de Timothy A. Clary-Pool/Getty Images) / Getty Images)

FLASHBACK: BIDEN SUGGESTED TRAVEL BAN AGAINST TRUMP CORONAVIRUS WAS ‘XENOPHOBIC’

Also on Friday, the Biden administration decided to restrict travel from eight countries in southern Africa in response to the emergence of Omicron.

Moderna said in a press release that he had previously tested a booster in healthy adults containing double the currently permitted dose. The drugmaker also “clinically studied two multivalent booster candidates designed to anticipate mutations such as those that have appeared in the Omicron variant,” the company said.

This file photo from June 14, 2021 shows a vial of Moderna COVID-19 vaccine (AP Photo / Eugene Hoshiko) (AP Photo/Eugene Hoshiko/AP Newsroom)

OMICRON COVID-19 VARIANT: HERE’S WHAT WE KNOW

As a third pillar of its strategy, Moderna said it would “rapidly advance a specific Omicron booster candidate,” nothing the company “has repeatedly demonstrated to be able to get new candidates through clinical testing. in 60 to 90 days ”.

“From the start, we have said that as we seek to defeat the pandemic, it is imperative that we be proactive as the virus evolves,” Moderna CEO Stéphane Bancel said in a statement. “Mutations in the Omicron variant are cause for concern and for the past several days we have been working to execute our strategy as quickly as possible to combat this variant. “

Havertown, Pennsylvania. October 25: A COVID-19 vaccination clinic was held on Monday, October 25, 2021 at the Township of Haverford municipal building for area first responders and those eligible for booster shots of all three vaccines. More than 180 vaccines have been (Pete Bannan/MediaNews Group/Daily Times via Getty Images/Getty Images)
Teleprinter Security Last Changer Changer %
MRNA MODERN, INC. 329.63 +56.24 +20,57%
PFE PFIZER INC. 54,00 +3.11 +6.11%
JNJ JOHNSON & JOHNSON 159.20 -1.04 -0,65%

GET FOX BUSINESS ON THE GO BY CLICKING HERE

Pfizer and BioNTech announced that their joint COVID-19 mRNA vaccine could be changed within 100 days to specifically counter Omicron, while Johnson & Johnson told FOX Business it is already testing its vaccine against the new variant.

Julia Musto of FOX Business and Peter Aitken of FOX News contributed to this report.

LEAVE A REPLY

Please enter your comment!
Please enter your name here